Pressreleases

Aveva Drug Delivery Systems Inc Welcomes New Director of Alliance Management and New Marketing Manager

Aveva Drug Delivery Systems Inc. hired Paul Davis as director, Alliance Management and Jared Hahn as marketing manager, both will join the Business Development Department reporting directly to Robert J Bloder, vice president. P

scION – New Ca/Mg Sensor for Always Reliable Results

Metrohm is pleased to launch scION, a new sensor based on thick-film technology. The sensor’s ion-selective tip has been specially developed for titrating calcium/magnesium hardness in drinking water.

Malvern Kinexus Installed in New GMP Testing Facility at NMI Reutlingen

Used for biomaterials characterisation in field of regenerative medicine.

BioPharm Insight Provides Forward-Looking Intelligence to the Biotechnology & Pharmaceutical Industry

BioPharm Insight, the premier data and intelligence provider for Biotechs, Pharmas, CROs, Service Providers and financial professionals in the Healthcare and Medtech markets, is pleased to announce the launch of its new, upgraded product platform. The new platform features proprietary, forward-looking intelligence, new search functionality, a worldwide reference list of approved drugs and drug sales projections by indication.

Corning Announces Availability of Shorty Stripette® Serological Pipets

Product line extension provides researchers with enhanced functionality and comfort.

Olink Bioscience Newsletter January 2011

There are now more than 100 scientific publications using in situ PLA technology and the Duolink kit!

Zetasizer Nano Supports Functional Nanoparticle Development at Micromod Partikeltechnologie GmbH

Researchers at micromod Partikeltechnologie GmbH are using the Zetasizer Nano particle characterisation system from Malvern Instruments, equipped with an MPT-2 Autotitrator and degasser, to determine particle size and to measure the zeta potential of nanoparticles as a function of pH.

Eurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CIS

Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, and Nycomed, a privately owned global pharmaceutical company, announced today that Eurand has entered into an exclusive commercialisation, license and supply agreement with Nycomed for Russia and the Commonwealth of Independent States (CIS), as well as Georgia and Mongolia. Financial terms were not disclosed.

Particle and Molecular Characterisation Focus for Malvern Instruments Short Courses at Pittcon 2011

Malvern Instruments will run two one-day short courses as part of the established program at Pittcon 2011on 13-18 March 2011 in Atlanta, GA, US.